🔎 Trials Near Me

Home › Ventricular Tachycardia › Pennsylvania

Ventricular Tachycardia clinical trials in Pennsylvania

7 studies for Ventricular Tachycardia are looking for participants at sites in Pennsylvania.

Cities in Pennsylvania

Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study

  • Penn State Health Milton S. Hershey Medical Center, Hershey
  • University of Pennsylvania, Philadelphia
Recruiting
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07324031

Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)

  • Hospital of the University of Pennsylvania, Philadelphia
Recruiting
Ages 18 to 85 · All sexes · Updated Sep 3, 2026 · NCT06703489

Cryoablation for Monomorphic Ventricular Tachycardia (VTS)

  • Hospital of University of Pennsylvania, Philadelphia
Recruiting
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07650032

Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)

  • University of Pennsylvania, Philadelphia
  • University of Pittsburgh Medical Center, Pittsburgh
Recruiting
Ages 18 and older · All sexes · Updated Apr 22, 2026 · NCT05765175

Randomized Assessment of TcMS for VT Storm

  • Hospital of the University of Pennsylvania, Philadelphia
Recruiting
Ages 18 and older · All sexes · Updated Apr 21, 2026 · NCT05599022

Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation

  • Hospital of the University of Pennsylvania, Philadelphia
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT05377216

Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT

  • Hospital of the University of Pennsylvania, Philadelphia
Recruiting
Ages 18 and older · All sexes · Updated Aug 14, 2025 · NCT05337241

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.